Your browser doesn't support javascript.
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation.
Antonelli, Guido; Focosi, Daniele; Turriziani, Ombretta; Tuccori, Marco; Brandi, Rossella; Fillo, Silvia; Ajassa, Camilla; Lista, Florigio; Mastroianni, Claudio M.
  • Antonelli G; Department of Molecular Medicine, Sapienza University of Rome, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
  • Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: daniele.focosi@gmail.com.
  • Turriziani O; Department of Molecular Medicine, Sapienza University of Rome, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
  • Tuccori M; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Unit of Adverse Drug Reactions Monitoring, Pisa University Hospital, Pisa, Italy.
  • Brandi R; Scientific Department, Army Medical Center, Rome, Italy.
  • Fillo S; Scientific Department, Army Medical Center, Rome, Italy.
  • Ajassa C; Department of Public Health and Infectious Diseases, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
  • Lista F; Scientific Department, Army Medical Center, Rome, Italy.
  • Mastroianni CM; Department of Public Health and Infectious Diseases, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
Clin Microbiol Infect ; 28(12): 1657-1658, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1914263
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-HIV Agents / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.cmi.2022.06.029

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-HIV Agents / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.cmi.2022.06.029